Do Not Do Recommendation

 
Do not routinely offer fibrates for the prevention of CVD to any of the following: -people who are being treated for primary prevention -people who are being treated for secondary prevention -people with CKD -people with type 1 diabetes -people with type 2 diabetes.

Do Not Do Recommendation Details

Recommendation:
Do not routinely offer fibrates for the prevention of CVD to any of the following: -people who are being treated for primary prevention -people who are being treated for secondary prevention -people with CKD -people with type 1 diabetes -people with type 2 diabetes.
Interventions:
fibrates

Source guidance details

Guidance:
Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease (CG181)
Published date:
July 2014
Paragraph number:
1.3.45
Page number:
24

View all NICE do not do from this Guidance